|
Market Closed -
Hong Kong S.E.
04:08:20 2026-10-20 am EDT
|
5-day change | 1st Jan Change | ||
| 5.730 HKD | -2.05% |
|
-14.48% | -49.69% |
| 11:35pm | Ascletis Reports Positive Preclinical Data for Once-Weekly Oral Obesity Drug Pipeline | MT |
| Oct. 02 | Ascletis Pharma Presents Preclinical Data for Weight Loss Drug at European Conference | MT |
| Market Cap | 5.27B 6.18B 788M 702M 651M 592M 1.11B 74.7B 1.13B 7.8B 3.07B 39.04B 2.96B 2.89B 125B | P/E 2026 * |
-7.92x | P/E 2027 * | -6.32x |
|---|---|---|---|---|---|
| Enterprise Value | 3.38B 3.96B 505M 450M 417M 379M 711M 47.85B 723M 5B 1.97B 25.01B 1.89B 1.85B 79.95B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 68x |
| Free-Float |
34.02% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 1672 | Delayed | |
OTC Markets
| ASCLF | Delayed | |
|
Deutsche Boerse AG
| 2VJ | Delayed | |
|
Tradegate
| 2VJ | Real-time | |
|
Börse Stuttgart
| 2VJ | Delayed | |
|
Boerse Muenchen
| 2VJ | Real-time |
| 1 day | -2.05% | ||
| 1 week | -14.48% | ||
| Current month | -31.50% | ||
| 1 month | -38.05% | ||
| 3 months | -33.76% | ||
| 6 months | -69.23% | ||
| Current year | -49.69% |
| 1 week | 5.4 |  | 6.88 |
| 1 month | 5.4 | | 9.6 |
| Current year | 5.4 | | 19.86 |
| 1 year | 5.4 | | 19.86 |
| 3 years | 0.76 | | 19.86 |
| 5 years | 0.76 | | 19.86 |
| 10 years | 0.76 | | 19.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jinzi Wu
CEO | Chief Executive Officer | 63 | 2013-04-25 |
Yan Yuemei
CTO | Chief Tech/Sci/R&D Officer | - | - |
Handan He
CTO | Chief Tech/Sci/R&D Officer | - | 2019-10-06 |
| Director | Title | Age | Since |
|---|---|---|---|
Jinzi Wu
CHM | Chairman | 63 | 2018-03-29 |
Jiong Gu
BRD | Director/Board Member | 53 | 2018-03-31 |
| Director/Board Member | 52 | 2019-03-12 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/21/26 | Other | Chief Executive Officer | -1,300,000 | 0.1217% | ||
| 7/21/26 | Other | Chief Operating Officer | -1,300,000 | 0.1217% | ||
| 2/10/26 | Other | Chief Operating Officer | 1,300,000 | 0.1301% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.05% | -14.48% | -39.04% | +223.73% | 787M | |
| -1.33% | +4.88% | +54.50% | +109.94% | 1,106B | |
| -0.69% | -3.77% | +31.35% | +66.62% | 612B | |
| -0.96% | +0.55% | +23.13% | +94.26% | 500B | |
| +1.93% | +7.70% | +37.85% | +62.13% | 367B | |
| -1.59% | -1.25% | +69.39% | +43.02% | 354B | |
| +1.05% | +5.13% | +20.43% | +47.90% | 286B | |
| +0.91% | +5.11% | -0.48% | +19.88% | 256B | |
| -1.75% | +1.76% | +42.21% | +51.44% | 230B | |
| -2.00% | +1.75% | +24.64% | +95.14% | 190B | |
| Average | +0.17% | +0.32% | +26.40% | +81.41% | 390.09B | |
| Weighted average by Cap. | +0.50% | +2.30% | +38.33% | +75.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 69.01M 80.99M 10.32M 9.2M 8.52M 7.75M 14.54M 978M 14.78M 102M 40.19M 511M 38.72M 37.91M 1.63B |
| Net income | -654M -768M -97.8M -87.18M -80.76M -73.43M -138M -9.27B -140M -969M -381M -4.85B -367M -359M -15.49B | -822M -965M -123M -110M -102M -92.29M -173M -11.65B -176M -1.22B -479M -6.09B -461M -452M -19.47B |
| Net Debt | -1.89B -2.22B -283M -252M -234M -213M -399M -26.85B -405M -2.8B -1.1B -14.03B -1.06B -1.04B -44.86B | -577M -677M -86.22M -76.85M -71.19M -64.73M -121M -8.17B -123M -854M -336M -4.27B -323M -317M -13.66B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-20 | HK$5.730 | -2.05% | 1,427,000 |
| 26-10-16 | HK$5.850 | +1.12% | 3,419,000 |
| 26-10-15 | HK$5.785 | -1.62% | 5,780,000 |
| 26-10-14 | HK$5.880 | -12.24% | 4,129,000 |
| 26-10-13 | HK$6.700 | -2.05% | 2,274,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1672 Stock
Select your edition
All financial news and data tailored to specific country editions
